Clinical Trial Update: Fluorescence Cystoscopy and Optimized MMC in Recurrent Bladder Cancer (FinnBladder 9) [Phase 3]

View source ↗

Summary

Phase 3 trial update investigating fluorescence cystoscopy and optimized mitomycin C for recurrent bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Snippet

Sponsor: Turku University Hospital | Conditions: Bladder Cancer | Phase 3 | Status: UNKNOWN